China Resources Boya Bio pharmaceutical Group Co Ltd. Stock Analysis 300294.SZ

China Resources Boya Bio-pharmaceutical Group Co., Ltd. manufactures pharmaceutical products. The company is headquartered in Fuzhou, Jiangxi and currently employs 1,947 full-time employees. The company went IPO on 2012-03-08. The firm mainly operates its business through five segments. The Blood Products Business segment mainly engages in the research and development, production and sales of blood products including albumin series, immunoglobulins series and coagulation factors series products. The Diabetes Medicine Business segment engages in the production and sales of diabetes and other categories of medicine. The Biochemical Pharmaceutical Business segment engages in the research and development, production and sales of biochemical medicine. The Pharmaceutical Distribution Business segment engages in the pharmaceutical distribution business. The Other Business segment engages in biotechnology development and other businesses. The firm conducts its business in the domestic market.